Expression of a mutant retinoic acid receptor β alters lineage differentiation in mouse embryonic stem cells

Stem Cells and Development

Volumn 19, Issue 7, 2010, Pages 951-960

  Chatzi, Christina ^a   Van Den Brink, Christina E ^b   Van Der Saag, Paul T ^b   McCaig, Colin D ^a   Shen, Sanbing ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; MICROTUBULE ASSOCIATED PROTEIN 2; MUTANT PROTEIN; NESTIN; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR NKX2.5; ANTINEOPLASTIC AGENT; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BLASTOCYST; BLASTOCYTE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; GENE DELETION; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NERVE CELL; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; ANIMAL; ANIMAL EMBRYO; APOPTOSIS; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; HUMANS; MICE; NEURONS; RECEPTORS, RETINOIC ACID; SEQUENCE DELETION; TRETINOIN;

EID: 77954916991     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0517     Document Type: Article

References (27)

1. Edwards MK and MW McBurney. (1983). The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev Biol 98: 187-191.
2. Wobus AM, J Rohwedel, V Maltsev and J Hescheler. (1994). In vitro differentiation of embryonic stem cells into cardiomyocytes or skeletal muscle cells is specifically modulated by retinoic acid. Rouxs Arch Dev Biol 204: 36-45.
3. Rohwedel J, K Guan and AM Wobus. (1999). Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs (Print) 165: 190-202.
4. Soprano DR, BW Teets and KJ Soprano. (2007). Role of retinoic Acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm 75: 69-95.
5. Kurokawa R, VC Yu, A Naar, S Kyakumoto, Z Han, S Silverman, MG Rosenfeld and CK Glass. (1993). Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev 7 (7B): 1423-1435.
6. Zechel C, XQ Shen, JY Chen, ZP Chen, P Chambon and H Gronemeyer. (1994). The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J 13: 1425-1433.
7. Mark M, NB Ghyselinck and P Chambon. (2009). Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 7: e002.
8. de The H, MM Vivanco-Ruiz, P Tiollais, H Stunnenberg and A Dejean. (1990). Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343: 177-180.
9. Sucov HM, KK Murakami and RM Evans. (1990). Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. Proc Natl Acad Sci USA 87: 5392-5396.
10. Shen S, FA Kruyt, J den Hertog, PT van der Saag and W Kruijer. (1991). Mouse and human retinoic acid receptor beta 2 promoters: sequence comparison and localization of retinoic acid responsiveness. DNA Seq 2: 111-119.
11. Shen S, CE van den Brink, W Kruijer and PT van der Saag. (1992). Embryonic stem cells stably transfected with mRAR beta 2-lacZ exhibit specific expression in chimeric embryos. Int J Dev Biol 36: 465-476.
12. Shen S, PT van der Saag and W Kruijer. (1993). Dominant negative retinoic acid receptor beta. Mech Dev 40: 177-189.
13. Chatzi C, RH Scott, J Pu, B Lang, C Nakamoto, CD McCaig and S Shen. (2009). Derivation of homogeneous GABAergic neurons from mouse embryonic stem cells. Exp Neurol 217: 407-416.
14. Liour SS, SA Kraemer, MB Dinkins, CY Su, M Yanagisawa and RK Yu. (2006). Further characterization of embryonic stem cellderived radial glial cells. Glia 53: 43-56.
15. Espeseth AS, SP Murphy and E Linney. (1989). Retinoic acid receptor expression vector inhibits differentiation of F9 embryonal carcinoma cells. Genes Dev 3: 1647-1656.
16. Pratt MA, J Kralova and MW McBurney. (1990). A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 10: 6445-6453.
17. Kruyt FA, LJ van der Veer, S Mader, CE van den Brink, A Feijen, LJ Jonk, W Kruijer and PT van der Saag. (1992). Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RAR alpha. Differentiation 49: 27-37.
18. Costa SL and MW McBurney. (1996). Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA. Exp Cell Res 225: 35-43.
19. Minucci S, DJ Zand, A Dey, MS Marks, T Nagata, JF Grippo and K Ozato. (1994). Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells. Mol Cell Biol 14: 360-372.
20. Rochette-Egly C and P Chambon. (2001). F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. Histol Histopathol 16: 909-922.
21. Kruyt FA, CE van den Brink, LH Defize, MJ Donath, P Kastner, W Kruijer, P Chambon and PT van der Saag. (1991). Transcriptional regulation of retinoic acid receptor beta in retinoic acid-sensitive and-resistant P19 embryocarcinoma cells. Mech Dev 33: 171-178.
22. Jonk LJ, ME de Jonge, FA Kruyt, CL Mummery, PT van der Saag and W Kruijer. (1992). Aggregation and cell cycle dependent retinoic acid receptor mRNA expression in P19 embryonal carcinoma cells. Mech Dev 36: 165-172.
23. Honda M, TS Hamazaki, S Komazaki, H Kagechika, K Shudo and M Asashima. (2005). RXR agonist enhances the differentiation of cardiomyocytes derived from embryonic stem cells in serum-free conditions. Biochem Biophys Res Commun 333: 1334-1340.
24. Monteiro MC, B Wdziekonski, P Villageois, C Vernochet, C Iehle, N Billon and C Dani. (2009). Commitment of mouse embryonic stem cells to the adipocyte lineage requires retinoic acid receptor beta and active GSK3. Stem Cells Dev 18: 457-463.
25. Faria TN, C Mendelsohn, P Chambon and LJ Gudas. (1999). The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274: 26783-26788.
26. Turnpenny L, S Brickwood, CM Spalluto, K Piper, IT Cameron, DI Wilson and NA Hanley. (2003). Derivation of human embryonic germ cells: an alternative source of pluripotent stem cells. Stem Cells 21: 598-609.
27. Mountford P, J Nichols, B Zevnik, C O'Brien and A Smith. (1998). Maintenance of pluripotential embryonic stem cells by stem cell selection. Reprod Fertil Dev 10: 527-533.